Literature DB >> 3183575

The selective binding and transmigration of monocytes through the junctional complexes of human endothelium.

N A Pawlowski1, G Kaplan, E Abraham, Z A Cohn.   

Abstract

Human monocytes show a high affinity for vascular endothelium both in vitro and in vivo. To explore monocyte-endothelial interaction in greater detail, we have developed a new in vitro model for growth of human endothelial cells (EC). Human umbilical vein EC (HUVEC) cultured upon collagen gels form confluent monolayers of EC that bind silver at their intercellular border similar to cells in situ. Intercellular junctional structures, both adherens and tight junctions, were identified. In contrast, HUVEC grown on plastic surfaces did not stain with silver. The silver-staining characteristic of EC-collagen monolayers was reversible and related to their in vitro maturation and senescence. Silver staining of EC borders provided a grid by which the location of monocyte binding to the luminal surface of individual EC could be assessed. Using this technique, we found that monocytes preferentially bound to the margins of EC, in approximation to the silver-staining junctions. These results suggest that EC determinants recognized by monocytes occur in a unique topographical distribution on the apical face of EC. After binding, monocytes migrated through the EC monolayers at high basal rates. The lack of penetration of collagen gels in the absence of an EC monolayer suggested the generation of EC-specific chemotactic signal(s). Monocytes were observed to pass between EC without evidence of disruption of the monolayer. Silver stain remained present during all phases of migration, and under transmission electron microscopy, junctional complexes were found proximal to monocytes that had just completed their passage through the monolayer. After orientation to the basal surface of the EC monolayer, monocytes migrated randomly into the underlying collagen gel. Monocyte adherence, penetration, migration, and long term survival can be studied under these conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183575      PMCID: PMC2189117          DOI: 10.1084/jem.168.5.1865

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  48 in total

1.  Reactions to injury of vascular endothelium with special reference to the problem of thrombosis.

Authors:  V J McGOVERN
Journal:  J Pathol Bacteriol       Date:  1955 Jan-Apr

2.  Monocyte chemotactic factor produced by large vessel endothelial cells in vitro.

Authors:  J A Berliner; M Territo; L Almada; A Carter; E Shafonsky; A M Fogelman
Journal:  Arteriosclerosis       Date:  1986 May-Jun

3.  Generation of, lipid neutrophil chemoattractant activity by histamine-stimulated cultured endothelial cells.

Authors:  H W Farber; P F Weller; S Rounds; D J Beer; D M Center
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

4.  Monocyte kinetic studies in normal and disease states.

Authors:  G Meuret; G Hoffmann
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

5.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

6.  The mechanism of fibrin-induced disorganization of cultured human endothelial cell monolayers.

Authors:  B Weimar; U Delvos
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

7.  Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells.

Authors:  P E DiCorleto; C A de la Motte
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

8.  Human monocyte adherence to cultured vascular endothelium: monoclonal antibody-defined mechanisms.

Authors:  W J Wallis; P G Beatty; H D Ochs; J M Harlan
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature.

Authors:  M Simionescu; N Simionescu; G E Palade
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

10.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

View more
  26 in total

1.  Qualitative and quantitative analysis of monocyte transendothelial migration by confocal microscopy and three-dimensional image reconstruction.

Authors:  A V Andjelkovic; M R Zochowski; F Morgan; J S Pachter
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

2.  Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.

Authors:  Yuling Zhao; Matthew J Haney; Vivek Mahajan; Benjamin C Reiner; Anna Dunaevsky; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  J Nanomed Nanotechnol       Date:  2011-09-10

3.  Macrophages with cellular backpacks for targeted drug delivery to the brain.

Authors:  Natalia L Klyachko; Roberta Polak; Matthew J Haney; Yuling Zhao; Reginaldo J Gomes Neto; Michael C Hill; Alexander V Kabanov; Robert E Cohen; Michael F Rubner; Elena V Batrakova
Journal:  Biomaterials       Date:  2017-06-18       Impact factor: 12.479

4.  Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins.

Authors:  Alencia V Woodard-Grice; Alexis C McBrayer; John K Wakefield; Ya Zhuo; Susan L Bellis
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

Review 5.  Cell-mediated drug delivery.

Authors:  Elena V Batrakova; Howard E Gendelman; Alexander V Kabanov
Journal:  Expert Opin Drug Deliv       Date:  2011-02-24       Impact factor: 6.648

Review 6.  Assessing the barriers to image-guided drug delivery.

Authors:  Gregory M Lanza; Chrit Moonen; James R Baker; Esther Chang; Zheng Cheng; Piotr Grodzinski; Katherine Ferrara; Kullervo Hynynen; Gary Kelloff; Yong-Eun Koo Lee; Anil K Patri; David Sept; Jan E Schnitzer; Bradford J Wood; Miqin Zhang; Gang Zheng; Keyvan Farahani
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-31

7.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

8.  Monoclonal antibodies to lymphocyte function-associated antigen-1 inhibit invasion of human lymphoma and metastasis of murine lymphoma.

Authors:  R Harning; C Myers; V J Merluzzi
Journal:  Clin Exp Metastasis       Date:  1993-07       Impact factor: 5.150

9.  Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Authors:  Natalia L Klyachko; Matthew J Haney; Yuling Zhao; Devika S Manickam; Vivek Mahajan; Poornima Suresh; Shawn D Hingtgen; R Lee Mosley; Howard E Gendelman; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2013-11-18       Impact factor: 5.307

10.  Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors.

Authors:  L Maródi; S Schreiber; D C Anderson; R P MacDermott; H M Korchak; R B Johnston
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.